A widely used breast cancer drug may ease the side effects of prostate cancer treatment, according to a new German study. Scientists examined four studies involving men in Europe and North America undergoing therapy for prostate cancer, the common side effects of which are gynecomastia (breast enlargement) or breast pain. Read More.
Breast cancer drug may ease prostate cancer side effects Read More »
Men treated for prostate cancer who took aspirin regularly for other medical conditions were less likely to die of their cancer than patients who weren’t taking aspirin, according to a new study. Read More.
Aspirin May Aid Cancer Recovery Read More »
When it comes to eating meat, a guy’s choice of what he eats and how it is cooked may affect his risk of having advanced prostate cancer, a new study says. Read More
The way red meat is cooked can affect cancer risk Read More »
Intermittent androgen deprivation therapy (ADT) has some quality-of-life (QOL) benefits for men with metastatic prostate cancer, but overall survival times are inferior to those seen with continuous ADT, according to the findings of a 17-year study (SWOG9346) presented at the American Society for Clinical Oncology 2012 annual meeting. Read More.
Survival Better with Continuous ADT Read More »
Scientists at the Johns Hopkins Kimmel Cancer Center, working with Danish researchers, have developed a novel anticancer drug designed to travel — undetected by normal cells through the bloodstream until activated by specific cancer proteins. The drug, made from a weedlike plant, has been shown to destroy cancers and their direct blood supplies, acting like a “molecular grenade,” and sparing healthy blood vessels and tissues. Read More.
Drug from Mediterranean weed kills tumor cells in mice Read More »
A new study shows that prostate cancer surgery, which often leaves men impotent or incontinent, does not appear to save the lives of men with early-stage disease, who account for most cases, and many of these men would do just as well to choose no treatment at all. From the NY Times And a second article
Questioning Surgery for Early Prostate Cancer Read More »
Dr. Uri Lindner MD, FRCSC Uro-Oncology Fellow Princess Margaret Cancer Centre Toronto, ON, Canada Dr. Lindner is an associate of Dr. John Trachtenberg who has developed a ground-breaking approach to the treatment of prostate cancer. In general approach, this procedure has some similarities to a lumpectomy in the treatment of breast cancer. Despite its recent emergence as an option for treating prostate cancer, MR-guided laser focal therapy for prostate cancer is already earning international attention and attracting increasing interest. CLICK ON THE ARROW TO START THE VIDEO Complete Presentation “MR-guided Laser Focal Therapy for Prostate Cancer.” High Definition 35
VIDEO: Dr. Uri Lindner “MR-guided Laser Focal Therapy for Prostate Cancer.” Read More »
Eating oily fish regularly ‘can significantly cut risk of prostate death’ * Those who consume high levels of omega-3 are 34 to 40 per cent less likely to die from disease * Men over 50 more likely to develop a tumour, and there is a strong genetic element to it Read More.
Eating oily fish regularly can significantly cut risk of prostate death Read More »
A diabetes drug costing as little as 2p a tablet could offer a major breakthrough in the treatment of prostate cancer. Research has shown that the medicine, called metformin, causes tumours to shrink by slowing the rate at which cancerous cells grow. Read the article
Metformin, a diabetes drug, shrinks prostate tumours Read More »
Prostate cancer cells require androgens including testosterone to grow. A recent review in the British Journal of Urology International describes new classes of drugs that target androgens in novel ways, providing alternatives to the traditional methods that frequently carry high side effects. Read more.
New Ways to Target Androgens in Prostate Cancer Read More »